홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

(+)-Vincristine

HCID 5388993
노트반응

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
57-22-7
표준 SMILES
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1
InChIKey
OGWKCGZFUXNPDA-CFWMRBGOSA-N
분자식
C46H56N4O10
평균 분자량
824.972 g/mol
단동위원소 질량
824.39964399

이름 및 식별자

우선 이름
(+)-Vincristine
IUPAC
(6'S)-22-Oxo-2'beta-vincaleukoblastine
영어명
Vincristine
분자식
C46H56N4O10
분자량
824.96

이름 및 동의어

(+)-Vincristinemethyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(1R,13S,15R,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0,12.0,1]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.0LCRLeucidVincosidCristovinLeucristineVINCRISTINEPericristine10MG/50MG/50G

데이터베이스 식별자

CAS
57-22-7
PubChem CID
5388993
DTXSID
DTXSID1032278
ChEMBL
CHEMBL499458
UNII
5J49Q6B70F

물성

물리화학적 성질

녹는점
211 · 211-216 ºC
끓는 점
761.92 °C · 761.92°C (rough estimate)
밀도
1.1539 · 1.1539 (rough estimate)
굴절률
1.6 · 1.6000 (estimate)
저장 조건
-20 °C, · Store at -20°C, protect from light
용해도
Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
물리적 상태
가루
산도 계수 (pKa)
5.4 · 5.4(at 25℃)
안정성
안정적이지만 열에 민감할 수 있습니다. 강한 산화제와 호환되지 않습니다.
EPA
Vincristine (57-22-7)

화학적 성질

solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

ridadr
1544
독성
LD50 i.p. in mice: 5.2 mg/kg (Adamson)
포장분류
II
위험 등급
6.1(a)
유해 물질 데이터
57-22-7(Hazardous Substances Data)

화학 및 산업

응용 분야 · 4건

개요A complex dimeric alkaloid isolated from Vinca minor, this base has the structure given above based upon chemical and spectroscopic data. It resembles Vinblastine in its pharmacological action. Depending on the dosage, it causes either thrombocytosis with no effect upon the leucocytes, or thrombocytopenia accompanied by peucopenia in rats. Thrombocytosis persists even after prolonged treatment with drugs given in the correct dosage.

역사Vinblastine and vincristine were extracted from vinca, and researchers found that they are the main ingredient of vinca which have antitumor activity. This is an accidental harvest by hard work and inspiration during scientific research process. It was firstly reported as an important discovery by Annals of the New York Academy of Sciences, and one report was published by Robert Noble and Charles Thomas Beer . They demonstrated that vinblastine can cause severe leukopenia. In 1963, vincristine (trade name, Oncovin) developed by Eli Lilly was approved by the US FDA, it provided a good choice for tumor chemotherapy program and gradually became the essential tumor chemotherapy drugs. At the early stages of the study, vinblastine and vincristine are directly extracted from the vinca, but the cost is high, and the extraction efficiency is low . Especially the specific chiral monomer compounds with biological activity are difficult to obtain. In the following years, the researchers used genetic engineering, biosynthesis, chemical synthesis, and other technical methods to explore and optimize the production process of vinblastine drugs. In particular, the rise of asymmetric synthesis provides a more economical choice for the synthesis of vinblastine compounds and increases productivity to more than 22% . At the same time, the pharmaceutical dosage forms were developed from the beginning as simple sulfate injection to liposomal preparations and nanoparticle preparations, which improve the efficacy, reduce adverse reactions, and play better antitumor effect.

용도Antineoplastic[Note—Graphic formula same as for Vinblastine Sulfate, except that R is CHO].

일반 설명A white crystalline solid. Melting point 218°C. Used as an antineoplastic.

상·하류 제품 정보

상류 원료

황산벤젠

공급사100 곳

北京华美互利生物化工010-56205725 · [email protected]
成都普瑞法科技开发有限公司+86-028-82633397 18982077548 · [email protected]
成都曼思特生物科技有限公司18010516991 · [email protected]
南京普怡生物科技有限公司13814510036 · [email protected]
成都彼样生物科技有限公司18108052721 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
成都健腾生物技术有限公司028-85159085 18080455027 · [email protected]
云南西力生物技术股份有限公司0871-65217109 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
湖南瑞威尔生物科技有限公司18627957289 18173226957 · [email protected]
zhangjiagang vinsce bio-pharm. limited.86-512-58389969 · [email protected]
上海晶抗生物工程有限公司021-54721350 13524668266 · [email protected]
成都普思生物科技股份有限公司028-85370565-229 18080489829 · [email protected]
成都普菲德生物技术有限公司028-82610909 13388174823 · [email protected]
MedBio脉铂医药021-69568360 18916172912 · [email protected]
Zhejiang J&C Biological Technology Co.,Limited+1-2135480471 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
Aktin Chemicals, Inc.028-85159085 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
成都锦然生物科技有限公司028-83311324 1278112614 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
成都瑞芬思德丹生物科技有限公司2355253622; 18981954830 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海喀露蓝科技有限公司18149758185 18149758185 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
成都零六生物科技有限公司400-1166-196 13458535857 · [email protected]
雷丁试剂0510-85629785 18013409632 · [email protected]
上海卓因生物科技有限公司021-61317773 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海御略医药科技有限公司021-60345187 13671753212 · [email protected]
上海麦克林生化科技股份有限公司15221275939 15221275939 · [email protected]
上海永叶生物科技有限公司86-021-61559134 15921386130 · [email protected]
南京多隆生物科技有限公司18905173768 · [email protected]
南京百鑫德诺生物科技有限公司025-58849295 · [email protected]
上海兴鲁化工科技有限公司02120970332 · [email protected]
ALB Technology Limited702-983-3769 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
武汉德拜技术有限公司18086626237 18086626237 · [email protected]
上海语纯生物科技有限公司021-021-52273538 17321241593 · [email protected]
武汉天植生物技术有限公司18607101326 15172504745 · [email protected]
Wuhan ChemNorm Biotech Co.,Ltd.+86-27-8439 4403 18971486879 · [email protected]
广东翁江化学试剂有限公司0751-2886766 13927870850 · [email protected]
EMMX Biotechnology LLC888-539-0666 · [email protected]
上海西格生物科技有限公司021-57810052 18930344717 · [email protected]
南京博米尔生物科技有限公司025-83453382-8005 · [email protected]
山东西亚化学有限公司4009903999 13395398332 · [email protected]
上海澄绍生物科技有限公司021-61847300 13341622919 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트